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with an average of 97.3% (see Figure 1 for an example of pass-rate vs. 
gantry angle result). Using this method, a problem with the gantry 
motor control with one linac at our centre was found, which was 
corroborated (albeit at a much higher time cost) by commercial VMAT 
QA products, further proving its utility in a clinical setting. 
 
 
Figure 1. Chi results comparing EPID images to predicted images for 
each sub-arc during a complete VMAT delivery. 
 
Conclusions: The method provides a comprehensive and highly 
efficient pre-treatment verification of VMAT delivery using EPID. Dose 
delivery accuracy is assessed as a function of gantry angle to ensure 
accurate treatment. Individual Chi maps for small sub-arcs provide a 
useful tool for error diagnostics.  
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Purpose/Objective: In volumetric-modulated arc therapy (VMAT) 
gantry speed, multileaf collimator configuration, and dose rate vary 
continuously during delivery. For a safe clinical implementation of 
VMAT, accurate 3D dose verification is essential but also complicated. 
In our department, EPID-based in vivo dosimetry using a semi-
empirical back-projection model is clinically employed to verify all 
VMAT treatments. The purpose of this study was to investigate the 
sensitivity of our 3D in vivo EPID dosimetry approach to detecting 
patient-related errors during VMAT delivery. 
Materials and Methods: Treatment planning of VMAT was performed 
using the SmartArc module of the Pinnacle treatment planning 
system. In order to assess the sensitivity of our EPID-based in vivo 
dosimetry method, patient-related errors were simulated by changing 
position and dimension of an anthropomorphic (Alderson) phantom. 
The phantom was irradiated using a 2-arc head-and-neck (6 MV), 
prostate (10 MV) and lung (10MV) VMAT technique. The errors 
comprised a vertical and horizontal phantom shift of 2 cm, a 10 
degree rotation, and the addition of 1cm tissue-equivalent material. 
Dose distributions reconstructed from EPID images and the original 
planned dose distributions were compared using 3D γ evaluation using 
3% dose difference relative to the maximum dose, and 3 mm distance-
to-agreement as criteria.  
Results: Table 1 shows the 3D gamma evaluation of the total dose 
relative to the situation without errors. For the prostate treatment, 
the effect of the introduced errors is negligible, except that the 
reconstructed dose at the prescription point was 4.2% higher for a 
change in thickness of 1 cm. For the head-and-neck treatment, results 
for the gamma evaluation showed a larger sensitivity for the 
introduced errors. Also the dose difference at isocenter for the 
thickness error was larger: -7.8%. The results for the lung plan were 
similar to those for the prostate plan. 
 
 
 
 
 
 
 
 
 
 
Table 1. Gamma Evaluation Results (3%, ±3mm) and Relative Dose 
Differences at Isocenter for Introduced Errors 
Treatment 
Site  Error Type  γmean γ1% 
γ 
≤1(%)  
Relative Dose Difference 
at Isocenter(%)  
Prostate  
Vertical shift 0.41 1.2 96.7  0.8  
Horizontal 
shift  0.30 0.8 99.9  0.4  
Rotation  0.30 0.9 99.5  0.6  
Thickness  0.66 1.4 86.9  -4.2  
Head-and- 
Neck  
Vertical shift 0.90 3.8 69.6  1.1  
Horizontal 
shift  2.23 8.3 36.1  5.1  
Rotation  0.77 3.9 77.5  -1.2  
Thickness  0.81 2.5 72.1  -7.8  
Lung  
Vertical shift 0.42 1.2 97.4  -0.7  
Horizontal 
shift  0.35 1.0 98.9  -1.2  
Rotation  0.49 1.8 92.7  0.1  
Thickness  0.59 1.5 91.9  -7.0 
 
Conclusions: Our verification results show that vertical and horizontal 
shifts and a rotation of the order of 2cm and 10 degree, respectively, 
do not result in significant deviations between EPID reconstructed and 
treatment plan dose distributions for both prostate and lung VMAT 
treatments. The head-and-neck VMAT treatments are more sensitive 
for position errors. With VMAT, EPID dosimetry is often not able to 
detect patient position discrepancies, and should be combined with 
IGRT. However, changes in patient thickness are easily detected.  
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Purpose/Objective: For in vivo verification of IMRT and VMAT 
treatments a 3D dose reconstruction method based on EPID dosimetry 
is routinely applied in our clinic. After reconstruction, the in vivo dose 
is compared to the planned dose by means of a 3D γ analysis. 
Although this method is capable of detecting treatment deviations, 
the clinical relevance of γ parameters is far from obvious. Therefore, 
we wish to correlate the 3D γ evaluation results with other, clinically 
more common parameters used to determine the quality of a dose 
distribution, such as DVH and EUD parameters for specific regions of 
interest (ROIs). As a pilot study, head-and-neck (H&N) VMAT 
treatments were investigated. 
Materials and Methods: 18 treatments were selected having a variety 
of deviations in the in vivo dose, combined with a few treatments 
showing no deviations. For 56 fractions of these treatments, the 3D in 
vivo dose distribution was reconstructed. Several parameters were 
calculated for three different ROIs: the PTV, the volume enclosed by 
the 50% isodose surface and the volume enclosed by the 30% isodose 
surface minus the PTV. These ROIs were chosen to be representative 
for our current clinical portal dosimetry evaluation, and to clearly 
separate high- and low-dose regions. The calculated γ parameters 
were the γ pass rate, 99th percentile of the γ-distribution (γ1%) and 
the mean γ value. Differences between planned and reconstructed 
dose distributions were next evaluated for each ROI using DVH 
parameters D1, D50 and D99 and EUD(1), i.e., the mean dose and 
EUD(7), i.e., focusing on hot spots. Since γ values carry no sign, 
correlations between absolute deviations of DVH and EUD parameters 
and γ parameters were evaluated. 
Results: The table shows the obtained correlation coefficients. For all 
ROIs, strong correlations are observed between γ1%, mean γ and DVH 
and EUD parameters. The D99 parameters, however, hardly correlated 
with anything, except weakly with parameters of the 50% and 30%-PTV 
ROIs. 
 
 
 
 
 
 
